
<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>World Pharma News / Published News</title>
<link>http://www.worldpharmanews.net</link>
<description>World Pharma News .net - Web 2.0 pharmaceutical news portal  votes</description>
<pubDate>Sun, 05 Jul 2009 02:17:51 EEST</pubDate>
<language>en</language>
<item>
<title><![CDATA[Lu AA24530 shows positive results in major depressive disorder phase II study]]></title>
<link>http://www.worldpharmanews.net/ClinicalTrials/Lu_AA24530_shows_positive_results_in_major_depressive_disorder_phase_II_study/</link>
<comments>http://www.worldpharmanews.net/ClinicalTrials/Lu_AA24530_shows_positive_results_in_major_depressive_disorder_phase_II_study/</comments>
<pubDate>Sun, 05 Jul 2009 02:17:51 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Clinical Trials</category>
<guid>http://www.worldpharmanews.net/ClinicalTrials/Lu_AA24530_shows_positive_results_in_major_depressive_disorder_phase_II_study/</guid>
<description><![CDATA[H. Lundbeck A/S (Lundbeck) today announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD).<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Why Drugs Dona4t Work as They Should]]></title>
<link>http://www.worldpharmanews.net/Blogs/Why_Drugs_Donrsquot_Work_as_They_Should/</link>
<comments>http://www.worldpharmanews.net/Blogs/Why_Drugs_Donrsquot_Work_as_They_Should/</comments>
<pubDate>Sun, 05 Jul 2009 02:17:40 EEST</pubDate>
<dc:creator>eva</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Why_Drugs_Donrsquot_Work_as_They_Should/</guid>
<description><![CDATA[The average US adult is now regularly taking more than two prescription drugs at any given time. While pharmaceuticals continue to develop ever more elegant drugs, however, there is increasing concer<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[OpSec Security Identifies Alarming Trends in Illicit Bulk Pharmaceuticals and Drugs Online]]></title>
<link>http://www.worldpharmanews.net/Research_Development/OpSec_Security_Identifies_Alarming_Trends_in_Illicit_Bulk_Pharmaceuticals_and_Drugs_Online/</link>
<comments>http://www.worldpharmanews.net/Research_Development/OpSec_Security_Identifies_Alarming_Trends_in_Illicit_Bulk_Pharmaceuticals_and_Drugs_Online/</comments>
<pubDate>Sun, 05 Jul 2009 02:16:45 EEST</pubDate>
<dc:creator>kfailla</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/OpSec_Security_Identifies_Alarming_Trends_in_Illicit_Bulk_Pharmaceuticals_and_Drugs_Online/</guid>
<description><![CDATA[This two-year study assesses the increasing risks in counterfeiting pharmaceuticals in the online marketplace.<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa]]></title>
<link>http://www.worldpharmanews.net/ClinicalTrials/Schering-Plough_Announces_Phase_II_and_III_Data_for_Corifollitropin_Alfa/</link>
<comments>http://www.worldpharmanews.net/ClinicalTrials/Schering-Plough_Announces_Phase_II_and_III_Data_for_Corifollitropin_Alfa/</comments>
<pubDate>Sat, 04 Jul 2009 16:19:14 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Clinical Trials</category>
<guid>http://www.worldpharmanews.net/ClinicalTrials/Schering-Plough_Announces_Phase_II_and_III_Data_for_Corifollitropin_Alfa/</guid>
<description><![CDATA[Schering-Plough Corp., (NYSE: SGP) has announced results from the Phase III ENGAGE clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follic<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Pharmaceutical and Healthcare Market in Poland 2009]]></title>
<link>http://www.worldpharmanews.net/Research_Development/Pharmaceutical_and_Healthcare_Market_in_Poland_2009-1/</link>
<comments>http://www.worldpharmanews.net/Research_Development/Pharmaceutical_and_Healthcare_Market_in_Poland_2009-1/</comments>
<pubDate>Fri, 03 Jul 2009 10:53:21 EEST</pubDate>
<dc:creator>pmrcorporate</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/Pharmaceutical_and_Healthcare_Market_in_Poland_2009-1/</guid>
<description><![CDATA[In 2008 the pharmacy market in Poland was worth PLN 24.1bn (€6.9bn), which represented 11.5% growth in comparison with 2007. At present, it is one of the areas of the Polish economy which boasts the <br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Smoking Cessation Drugs Chantix, Wellbutrin, And Zyban Are Getting New]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Smoking_Cessation_Drugs_Chantix_Wellbutrin_And_Zyban_Are_Getting_New/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Smoking_Cessation_Drugs_Chantix_Wellbutrin_And_Zyban_Are_Getting_New/</comments>
<pubDate>Fri, 03 Jul 2009 10:50:37 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Smoking_Cessation_Drugs_Chantix_Wellbutrin_And_Zyban_Are_Getting_New/</guid>
<description><![CDATA[Will Warn About Risk Of Serious Neuropsychiatric Symptoms Including Agitation, Depression, Suicidal Thoughts, And Attempted Suicide<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Brandname Accutane Acne Medicine Is Being Removed From U.S. Market By Roche]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Brandname_Accutane_Acne_Medicine_Is_Being_Removed_From_U-S-_Market_By_Roche/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Brandname_Accutane_Acne_Medicine_Is_Being_Removed_From_U-S-_Market_By_Roche/</comments>
<pubDate>Fri, 03 Jul 2009 10:50:16 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Brandname_Accutane_Acne_Medicine_Is_Being_Removed_From_U-S-_Market_By_Roche/</guid>
<description><![CDATA[Accutane Recall Due To Safety Issues Or Declining Sales Or Lawsuit Losses Or  Some Combination Of These Factors?<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[European Medicines Agency recommends withdrawal of dextropropoxyphene-containing medicines]]></title>
<link>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_recommends_withdrawal_of_dextropropoxyphene-containing_medicines/</link>
<comments>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_recommends_withdrawal_of_dextropropoxyphene-containing_medicines/</comments>
<pubDate>Fri, 03 Jul 2009 10:49:50 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_recommends_withdrawal_of_dextropropoxyphene-containing_medicines/</guid>
<description><![CDATA[Finalising a review of the safety and efficacy of dextropropoxyphene-containing medicines, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that their r<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes]]></title>
<link>http://www.worldpharmanews.net/Product/ONGLYZA_saxagliptin_Receives_Positive_Opinion_in_Europe_for_the_Treatment_of_Type_2_Diabetes/</link>
<comments>http://www.worldpharmanews.net/Product/ONGLYZA_saxagliptin_Receives_Positive_Opinion_in_Europe_for_the_Treatment_of_Type_2_Diabetes/</comments>
<pubDate>Tue, 30 Jun 2009 21:46:09 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/ONGLYZA_saxagliptin_Receives_Positive_Opinion_in_Europe_for_the_Treatment_of_Type_2_Diabetes/</guid>
<description><![CDATA[AstraZeneca and Bristol-Myers Squibb Company today announced that their marketing authorisation application for ONGLYZA (saxagliptin) received a positive opinion from the Committee for Medicinal Prod<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Lundbeck receives FDA Complete Response Letter on Serdolect for the treatment of schizophrenia]]></title>
<link>http://www.worldpharmanews.net/Product/Lundbeck_receives_FDA_Complete_Response_Letter_on_Serdolect%AE_for_the_treatment_of_schizophrenia/</link>
<comments>http://www.worldpharmanews.net/Product/Lundbeck_receives_FDA_Complete_Response_Letter_on_Serdolect%AE_for_the_treatment_of_schizophrenia/</comments>
<pubDate>Sun, 28 Jun 2009 01:14:18 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Lundbeck_receives_FDA_Complete_Response_Letter_on_Serdolect%AE_for_the_treatment_of_schizophrenia/</guid>
<description><![CDATA[H. Lundbeck A/S (LUN.CO; LUN DC) has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for Serdolect® (sertindole) for the treatment of schizophrenia.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Generic Drug Maker Caraco Fails To Correct Manufacturing Problems First Discovered In May 2008]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Generic_Drug_Maker_Caraco_Fails_To_Correct_Manufacturing_Problems_First_Discovered_In_May_2008/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Generic_Drug_Maker_Caraco_Fails_To_Correct_Manufacturing_Problems_First_Discovered_In_May_2008/</comments>
<pubDate>Fri, 26 Jun 2009 23:53:17 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Generic_Drug_Maker_Caraco_Fails_To_Correct_Manufacturing_Problems_First_Discovered_In_May_2008/</guid>
<description><![CDATA[FDA And U.S. Marshals Seize Drug Products From Caraco's Three Michigan Facilities Due To Continuing Lack Of Quality Controls<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Obama Negotiates Reduction of Prescription Drug Costs]]></title>
<link>http://www.worldpharmanews.net/Blogs/Obama_Negotiates_Reduction_of_Prescription_Drug_Costs/</link>
<comments>http://www.worldpharmanews.net/Blogs/Obama_Negotiates_Reduction_of_Prescription_Drug_Costs/</comments>
<pubDate>Fri, 26 Jun 2009 23:52:56 EEST</pubDate>
<dc:creator>eva</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Obama_Negotiates_Reduction_of_Prescription_Drug_Costs/</guid>
<description><![CDATA[When people discuss the ever-rising costs of health care, one of the most common complaints is the sometimes exorbitant price of prescription medicines.<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[European Medicines Agency launches public consultation on new transparency policy]]></title>
<link>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_launches_public_consultation_on_new_transparency_policy/</link>
<comments>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_launches_public_consultation_on_new_transparency_policy/</comments>
<pubDate>Fri, 26 Jun 2009 00:30:32 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/European_Medicines_Agency_launches_public_consultation_on_new_transparency_policy/</guid>
<description><![CDATA[The European Medicines Agency is inviting comments on its draft transparency policy until 25 September 2009. Since its inauguration in 1995, the Agency has worked continuously to improve the transpar<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Sutent Significantly Improved Progression-Free Survival]]></title>
<link>http://www.worldpharmanews.net/ClinicalTrials/Sutent_Significantly_Improved_Progression-Free_Survival/</link>
<comments>http://www.worldpharmanews.net/ClinicalTrials/Sutent_Significantly_Improved_Progression-Free_Survival/</comments>
<pubDate>Fri, 26 Jun 2009 00:25:15 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Clinical Trials</category>
<guid>http://www.worldpharmanews.net/ClinicalTrials/Sutent_Significantly_Improved_Progression-Free_Survival/</guid>
<description><![CDATA[Pfizer has announced results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumors, also known as pancreatic neuroendocrine tumors, which<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Merck's Popular Asthma Drug Singulair Associated With Suicide And Depression]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Mercks_Popular_Asthma_Drug_Singulair_Associated_With_Suicide_And_Depression/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Mercks_Popular_Asthma_Drug_Singulair_Associated_With_Suicide_And_Depression/</comments>
<pubDate>Thu, 25 Jun 2009 00:08:58 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Mercks_Popular_Asthma_Drug_Singulair_Associated_With_Suicide_And_Depression/</guid>
<description><![CDATA[FDA Has Gone From &quot;No Link&quot; In January 2009 To Wanting An Increased Warning About These Neuropsychiatric Events In June 2009<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Gardasil Vaccine Associated With 28 Deaths In 2008 According To Judicial Watch Report]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Gardasil_Vaccine_Associated_With_28_Deaths_In_2008_According_To_Judicial_Watch_Report/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Gardasil_Vaccine_Associated_With_28_Deaths_In_2008_According_To_Judicial_Watch_Report/</comments>
<pubDate>Thu, 25 Jun 2009 00:08:47 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Gardasil_Vaccine_Associated_With_28_Deaths_In_2008_According_To_Judicial_Watch_Report/</guid>
<description><![CDATA[This Public Interest Group Reviewed Gardasil Cases Found In FDA's Vaccine Adverse Event Reporting System (VAERS)<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[World Pharmaceutical (China) Summit 2009 will be held in Shanghai]]></title>
<link>http://www.worldpharmanews.net/Conferences_Events/World_Pharmaceutical_China_Summit_2009_will_be_held_in_Shanghai/</link>
<comments>http://www.worldpharmanews.net/Conferences_Events/World_Pharmaceutical_China_Summit_2009_will_be_held_in_Shanghai/</comments>
<pubDate>Thu, 25 Jun 2009 00:08:38 EEST</pubDate>
<dc:creator>anitameng</dc:creator>
<category>Conferences &amp; Events</category>
<guid>http://www.worldpharmanews.net/Conferences_Events/World_Pharmaceutical_China_Summit_2009_will_be_held_in_Shanghai/</guid>
<description><![CDATA[World Pharmaceutical (China) Summit 2009 is one of the major international functions that link pharma executives from all over the world together.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission]]></title>
<link>http://www.worldpharmanews.net/Product/Nycomed_receives_Marketing_Authorization_for_Pantoprazole_20mg_OTC_from_European_Commission/</link>
<comments>http://www.worldpharmanews.net/Product/Nycomed_receives_Marketing_Authorization_for_Pantoprazole_20mg_OTC_from_European_Commission/</comments>
<pubDate>Tue, 23 Jun 2009 00:09:57 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Nycomed_receives_Marketing_Authorization_for_Pantoprazole_20mg_OTC_from_European_Commission/</guid>
<description><![CDATA[Nycomed received marketing authorisation from the European Commission for five applications: PANTOZOL Control®, PANTOLOC Control®, PANTECTA Control®, SOMAC Control® and CONTROLOC Control®. This new O<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[My Health: What Are Superfoods? Top 10 Facts (and Myths)]]></title>
<link>http://www.worldpharmanews.net/Blogs/My_Health_What_Are_Superfoods_Top_10_Facts_and_Myths/</link>
<comments>http://www.worldpharmanews.net/Blogs/My_Health_What_Are_Superfoods_Top_10_Facts_and_Myths/</comments>
<pubDate>Sat, 20 Jun 2009 14:43:25 EEST</pubDate>
<dc:creator>healthylivinggal</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/My_Health_What_Are_Superfoods_Top_10_Facts_and_Myths/</guid>
<description><![CDATA[Here are the top ten facts and myths about super foods.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[New zebrafish model offers new insights into skin cancer]]></title>
<link>http://www.worldpharmanews.net/Research_Development/New_zebrafish_model_offers_new_insights_into_skin_cancer/</link>
<comments>http://www.worldpharmanews.net/Research_Development/New_zebrafish_model_offers_new_insights_into_skin_cancer/</comments>
<pubDate>Sat, 20 Jun 2009 14:35:52 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Research &amp; Development</category>
<guid>http://www.worldpharmanews.net/Research_Development/New_zebrafish_model_offers_new_insights_into_skin_cancer/</guid>
<description><![CDATA[Scientists in the UK and Switzerland have identified a signalling pathway, PI3K (phosphoinositide 3-kinase) that shows promise as a target for treating aggressive skin cancer. Their results, based on<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Relatively Little Is Known About Long-Term Safety Of Bisphosphonates Such As Fosamax, Boniva, Actonel]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Relatively_Little_Is_Known_About_Long-Term_Safety_Of_Bisphosphonates_Such_As_Fosamax_Boniva_Actonel/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Relatively_Little_Is_Known_About_Long-Term_Safety_Of_Bisphosphonates_Such_As_Fosamax_Boniva_Actonel/</comments>
<pubDate>Sat, 20 Jun 2009 01:12:22 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Relatively_Little_Is_Known_About_Long-Term_Safety_Of_Bisphosphonates_Such_As_Fosamax_Boniva_Actonel/</guid>
<description><![CDATA[Doctors Should Inform Their Patients About Potential Serious Side Effects Like Osteonecrosis Of The Jaw And Femur Fractures<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: June 18 Congressional Subcommittee Meeting About Medical Device Safety Act of 2009]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_June_18_Congressional_Subcommittee_Meeting_About_Medical_Device_Safety_Act_of_2009/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_June_18_Congressional_Subcommittee_Meeting_About_Medical_Device_Safety_Act_of_2009/</comments>
<pubDate>Thu, 18 Jun 2009 00:04:06 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_June_18_Congressional_Subcommittee_Meeting_About_Medical_Device_Safety_Act_of_2009/</guid>
<description><![CDATA[This Bill, If Passed, Would Restore An Injured Patient's Right To Sue A Medical Device Manufacturer By Reversing Riegel v. Medtronic Ruling<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration]]></title>
<link>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</link>
<comments>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</comments>
<pubDate>Thu, 18 Jun 2009 00:03:52 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Boehringer_Ingelheim_and_Vitae_Pharmaceuticals_announce_a_major_collaboration/</guid>
<description><![CDATA[Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta-secretase (BACE) inhibitors for th<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Medication Errors Are One Of The Most Common Medical Mistakes, But Number Can Be Reduced]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Medication_Errors_Are_One_Of_The_Most_Common_Medical_Mistakes_But_Number_Can_Be_Reduced/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Medication_Errors_Are_One_Of_The_Most_Common_Medical_Mistakes_But_Number_Can_Be_Reduced/</comments>
<pubDate>Wed, 17 Jun 2009 02:49:11 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Medication_Errors_Are_One_Of_The_Most_Common_Medical_Mistakes_But_Number_Can_Be_Reduced/</guid>
<description><![CDATA[Two Reports From April 2009 Medical Journal Offer Possible Solutions To A Problem Which Affects At Least 1.5 Million People Per Year<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease]]></title>
<link>http://www.worldpharmanews.net/Product/Genzyme_Receives_European_Approval_of_Renvela_for_Patients_with_Chronic_Kidney_Disease/</link>
<comments>http://www.worldpharmanews.net/Product/Genzyme_Receives_European_Approval_of_Renvela_for_Patients_with_Chronic_Kidney_Disease/</comments>
<pubDate>Wed, 17 Jun 2009 02:47:16 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Genzyme_Receives_European_Approval_of_Renvela_for_Patients_with_Chronic_Kidney_Disease/</guid>
<description><![CDATA[Genzyme Corporation (Nasdaq: GENZ) announced that the European Commission has approved Renvela® (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease (CKD)<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Obama Urges Doctors to Back Health Care Plans]]></title>
<link>http://www.worldpharmanews.net/Blogs/Obama_Urges_Doctors_to_Back_Health_Care_Plans/</link>
<comments>http://www.worldpharmanews.net/Blogs/Obama_Urges_Doctors_to_Back_Health_Care_Plans/</comments>
<pubDate>Tue, 16 Jun 2009 10:02:46 EEST</pubDate>
<dc:creator>eva</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Obama_Urges_Doctors_to_Back_Health_Care_Plans/</guid>
<description><![CDATA[President Barack Obama continues to promote his health care proposals, urging doctors gathered in Chicago to support wider insurance coverage and targeted federal spending cuts.<br/><br/>1 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Store News and Armada Health Care Join Forces to Launch New Specialty Pharmacy Magazine]]></title>
<link>http://www.worldpharmanews.net/Publications/Drug_Store_News_and_Armada_Health_Care_Join_Forces_to_Launch_New_Specialty_Pharmacy_Magazine/</link>
<comments>http://www.worldpharmanews.net/Publications/Drug_Store_News_and_Armada_Health_Care_Join_Forces_to_Launch_New_Specialty_Pharmacy_Magazine/</comments>
<pubDate>Tue, 16 Jun 2009 10:00:39 EEST</pubDate>
<dc:creator>cbenz34</dc:creator>
<category>Publications</category>
<guid>http://www.worldpharmanews.net/Publications/Drug_Store_News_and_Armada_Health_Care_Join_Forces_to_Launch_New_Specialty_Pharmacy_Magazine/</guid>
<description><![CDATA[NEW YORK, June 15, 2009 (GLOBE NEWSWIRE) -- Drug Store News Group, in affiliation with Armada Health Care, today introduced a new magazine, Specialty Pharmacy, to serve the fastest-growing segment of<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Safety Biomarkers in Drug Development Conference to be held in Bratislava, Slovak Republic]]></title>
<link>http://www.worldpharmanews.net/Conferences_Events/Safety_Biomarkers_in_Drug_Development_Conference_to_be_held_in_Bratislava_Slovak_Republic/</link>
<comments>http://www.worldpharmanews.net/Conferences_Events/Safety_Biomarkers_in_Drug_Development_Conference_to_be_held_in_Bratislava_Slovak_Republic/</comments>
<pubDate>Tue, 16 Jun 2009 10:00:11 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Conferences &amp; Events</category>
<guid>http://www.worldpharmanews.net/Conferences_Events/Safety_Biomarkers_in_Drug_Development_Conference_to_be_held_in_Bratislava_Slovak_Republic/</guid>
<description><![CDATA[14th-15th September 2009, Bratislava, Slovak Republic.The issue of drug safety has never been higher on the agenda of the Food and Drug Administration (FDA), EMEA and other global regulatory agenci<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Have Yasmin-Related Blood Clot Side Effect Cases Flown Below Radar In US?]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Have_Yasmin-Related_Blood_Clot_Side_Effect_Cases_Flown_Below_Radar_In_US/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Have_Yasmin-Related_Blood_Clot_Side_Effect_Cases_Flown_Below_Radar_In_US/</comments>
<pubDate>Mon, 15 Jun 2009 00:04:24 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Have_Yasmin-Related_Blood_Clot_Side_Effect_Cases_Flown_Below_Radar_In_US/</guid>
<description><![CDATA[In Europe Reports Of Pulmonary Embolism And Deep Vein Thrombosis Were Made Soon After Yasmin Birth Control Pill Was Approved in 2000<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Live Blog: WHO Declares Flu Pandemic]]></title>
<link>http://www.worldpharmanews.net/Blogs/Live_Blog_WHO_Declares_Flu_Pandemic/</link>
<comments>http://www.worldpharmanews.net/Blogs/Live_Blog_WHO_Declares_Flu_Pandemic/</comments>
<pubDate>Mon, 15 Jun 2009 00:04:07 EEST</pubDate>
<dc:creator>alex</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Live_Blog_WHO_Declares_Flu_Pandemic/</guid>
<description><![CDATA[The World Health Organization is declaring the first full-blown flu pandemic in 41 years. The disease, of course, is the H1N1 flu, the new strain that has been spreading in recent months. Raising the<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[The Lancet publishes direct comparison study between liraglutide and exenatide]]></title>
<link>http://www.worldpharmanews.net/ClinicalTrials/The_Lancet_publishes_direct_comparison_study_between_liraglutide_and_exenatide/</link>
<comments>http://www.worldpharmanews.net/ClinicalTrials/The_Lancet_publishes_direct_comparison_study_between_liraglutide_and_exenatide/</comments>
<pubDate>Mon, 15 Jun 2009 00:03:40 EEST</pubDate>
<dc:creator>PharmaNewsEU</dc:creator>
<category>Clinical Trials</category>
<guid>http://www.worldpharmanews.net/ClinicalTrials/The_Lancet_publishes_direct_comparison_study_between_liraglutide_and_exenatide/</guid>
<description><![CDATA[The Lancet has published online the results of the LEAD™ 6 study, a direct comparison between two products in a new class of diabetes treatments, the GLP-1 receptor agonists. Results show that patien<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe]]></title>
<link>http://www.worldpharmanews.net/Product/Takeda_to_Revise_Timing_of_Alogliptin_and_AlogliptinACTOS_MAA_Filing_in_Europe/</link>
<comments>http://www.worldpharmanews.net/Product/Takeda_to_Revise_Timing_of_Alogliptin_and_AlogliptinACTOS_MAA_Filing_in_Europe/</comments>
<pubDate>Mon, 15 Jun 2009 00:03:23 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Takeda_to_Revise_Timing_of_Alogliptin_and_AlogliptinACTOS_MAA_Filing_in_Europe/</guid>
<description><![CDATA[Takeda Pharmaceutical Company Limited (&quot;Takeda&quot;) has reviewed the development strategy for the Marketing Authorization Applications (MAAs) for its investigational compounds, alogliptin and aloglipt<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China]]></title>
<link>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</link>
<comments>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</comments>
<pubDate>Thu, 11 Jun 2009 21:08:35 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/GSK_and_Shenzhen_Neptunus_create_new_alliance_to_develop_and_manufacture_influenza_vaccines_in_China/</guid>
<description><![CDATA[GlaxoSmithKline plc (GSK) has entered into a definitive agreement to form a new Joint Venture with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd (Shenzhen Neptunus) focused on developing and manu<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Sanofi-aventis to strengthen Insulin Production Capacities]]></title>
<link>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</link>
<comments>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</comments>
<pubDate>Thu, 11 Jun 2009 21:08:24 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/Sanofi-aventis_to_strengthen_Insulin_Production_Capacities/</guid>
<description><![CDATA[Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that Sanofi-Aventis Deutschland GmbH has purchased from Pfizer the Diabel manufacturing plant in Frankfurt-Höchst, Germany, one of the largest s<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Drug Injury Watch: Lancet Article About Avandia Study Omits Key Fact Says Nissen And Other Critics]]></title>
<link>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Lancet_Article_About_Avandia_Study_Omits_Key_Fact_Says_Nissen_And_Other_Critics/</link>
<comments>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Lancet_Article_About_Avandia_Study_Omits_Key_Fact_Says_Nissen_And_Other_Critics/</comments>
<pubDate>Wed, 10 Jun 2009 00:52:05 EEST</pubDate>
<dc:creator>tjlpa</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Drug_Injury_Watch_Lancet_Article_About_Avandia_Study_Omits_Key_Fact_Says_Nissen_And_Other_Critics/</guid>
<description><![CDATA[Whether Avandia Causes Heart Attacks Remains An Open Issue, Despite Recent RECORD Study Results<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Update on Lu AA21004 clinical development programme in major depressive disorder (MDD)]]></title>
<link>http://www.worldpharmanews.net/ClinicalTrials/Update_on_Lu_AA21004_clinical_development_programme_in_major_depressive_disorder_MDD/</link>
<comments>http://www.worldpharmanews.net/ClinicalTrials/Update_on_Lu_AA21004_clinical_development_programme_in_major_depressive_disorder_MDD/</comments>
<pubDate>Wed, 10 Jun 2009 00:51:51 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Clinical Trials</category>
<guid>http://www.worldpharmanews.net/ClinicalTrials/Update_on_Lu_AA21004_clinical_development_programme_in_major_depressive_disorder_MDD/</guid>
<description><![CDATA[H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly have announced headline results from the first three clinical trials in the phase III development programme with <br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[4th Annual Clinical Site Partnerships in Central &amp; Eastern Europe, to be held in Budapest, Hungary]]></title>
<link>http://www.worldpharmanews.net/Conferences_Events/4th_Annual_Clinical_Site_Partnerships_in_Central__Eastern_Europe_to_be_held_in_Budapest_Hungary/</link>
<comments>http://www.worldpharmanews.net/Conferences_Events/4th_Annual_Clinical_Site_Partnerships_in_Central__Eastern_Europe_to_be_held_in_Budapest_Hungary/</comments>
<pubDate>Wed, 10 Jun 2009 00:51:34 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Conferences &amp; Events</category>
<guid>http://www.worldpharmanews.net/Conferences_Events/4th_Annual_Clinical_Site_Partnerships_in_Central__Eastern_Europe_to_be_held_in_Budapest_Hungary/</guid>
<description><![CDATA[7th-8th Septermber 2009, Budapest, Hungary.Central &amp; Eastern Europe continues be one of the most attractive regions globally for running clinical trials. With it's substantial pool of patients, ce<br/><br/>3 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Network Marketing Top Earners]]></title>
<link>http://www.worldpharmanews.net/Blogs/Network_Marketing_Top_Earners/</link>
<comments>http://www.worldpharmanews.net/Blogs/Network_Marketing_Top_Earners/</comments>
<pubDate>Tue, 09 Jun 2009 00:28:31 EEST</pubDate>
<dc:creator>davidmoses71</dc:creator>
<category>Blogs</category>
<guid>http://www.worldpharmanews.net/Blogs/Network_Marketing_Top_Earners/</guid>
<description><![CDATA[David Moses is recognized as a dynamic speaker, trainer, and success coach in the direct sales industry. His ability to sponsor, teach, and duplicate has resulted in many successful team members arou<br/><br/>4 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[Fourth confirmed swine flu case]]></title>
<link>http://www.worldpharmanews.net/Publications/Fourth_confirmed_swine_flu_case/</link>
<comments>http://www.worldpharmanews.net/Publications/Fourth_confirmed_swine_flu_case/</comments>
<pubDate>Tue, 09 Jun 2009 00:27:24 EEST</pubDate>
<dc:creator>eva</dc:creator>
<category>Publications</category>
<guid>http://www.worldpharmanews.net/Publications/Fourth_confirmed_swine_flu_case/</guid>
<description><![CDATA[A man who has recently returned from Florida has tested positive. He is being treated with anti-virals and is recovering at home.<br/><br/>2 Vote(s) ]]></description>
</item>

<item>
<title><![CDATA[World Health Organization grants Global Prequalification to GSK's Rotarix vaccine]]></title>
<link>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</link>
<comments>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</comments>
<pubDate>Tue, 09 Jun 2009 00:26:35 EEST</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Corporate</category>
<guid>http://www.worldpharmanews.net/Corporate/World_Health_Organization_grants_Global_Prequalification_to_GSKs_Rotarix%C2%99_vaccine/</guid>
<description><![CDATA[The World Health Organisation (WHO) has awarded global prequalification to GlaxoSmithKline Biologicals' vaccine against rotavirus, Rotarix™.Additionally, the WHO's Strategic Advisory Group of Exper<br/><br/>2 Vote(s) ]]></description>
</item>

</channel>
</rss>
